- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.12. | Sanuwave: UltraMIST-System in Einkaufsnetzwerk von Healogics aufgenommen | 2 | Investing.com Deutsch | ||
| SANUWAVE HEALTH Aktie jetzt für 0€ handeln | |||||
| 08.12. | Sanuwave's UltraMIST added to Healogics iSupply purchasing network | 2 | Investing.com | ||
| 08.12. | SANUWAVE Health, Inc.: Sanuwave Announces the Addition of UltraMIST to Healogics Group Purchasing Organization (GPO), iSupply | 1 | GlobeNewswire (USA) | ||
| 07.11. | SANUWAVE targets $13M-$14M Q4 revenue while leveraging post-CMS rule clarity | 2 | Seeking Alpha | ||
| 07.11. | SANUWAVE Health GAAP EPS of $0.46 beats by $0.14, revenue of $11.5M beats by $0.07M | 1 | Seeking Alpha | ||
| 07.11. | SANUWAVE Health, Inc.: Sanuwave Announces Q3 FY2025 Financial Results | 115 | GlobeNewswire (Europe) | Q3 2025 revenues were $11.5 million, up 22% from $9.4 million in Q3 2024. This represents the highest quarterly revenues in Company history. Q3 2025 gross margin was 77.9%, versus 75.5% in Q3 2024.... ► Artikel lesen | |
| 07.11. | SANUWAVE Health, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 06.11. | SANUWAVE Health, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 05.11. | An Overview of SANUWAVE Health's Earnings | 1 | Benzinga.com | ||
| 03.11. | SANUWAVE Health, Inc.: CMS Publishes Final Rule for Calendar Year 2026 Physician Fee Schedule for UltraMIST Procedure (CPT code 97610) | 4 | GlobeNewswire (USA) | ||
| 30.10. | SANUWAVE Health, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 06.10. | Sanuwave reports record quarterly revenue of $11.4-11.6 million | 1 | Investing.com | ||
| 06.10. | Sanuwave Health expects Q3 revenue between $11.4M and $11.6M | 1 | Seeking Alpha | ||
| 06.10. | SANUWAVE Health, Inc.: Sanuwave Health Announces Preliminary Revenue Results for the Third Quarter 2025 (Ended September 30, 2025) | 126 | GlobeNewswire (Europe) | Sanuwave announces preliminary revenues of $11.4 million to $11.6 million for the third quarter ended September 30, 2025. This represents the highest quarterly revenues in Company history. Q3 2025... ► Artikel lesen | |
| 01.10. | Sanuwave Health baut Führungsebene um: Daniel Coyle wird neuer Chief Operating Officer | 1 | Investing.com Deutsch | ||
| 30.09. | Sanuwave Health is a buy, this analyst says | 1 | Cantech Letter | ||
| 26.09. | SANUWAVE Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 26.09. | Sanuwave refinances debt with new credit facility | 1 | Seeking Alpha | ||
| 26.09. | Sanuwave Health refinances $27.5 million debt with J.P. Morgan facility | 3 | Investing.com | ||
| 26.09. | SANUWAVE Health, Inc.: Sanuwave Announces Strategic Debt Refinancing with New Credit Facility | 766 | GlobeNewswire (Europe) | Credit facility from J.P. Morgan consists of a four-year term loan of $23 million and a two-year $5 million revolving credit facility backed by accounts receivable Both the term loan and revolver... ► Artikel lesen |
1 2 3 Weiter >>
42 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDLINE | 40,450 | 0,00 % | Aktien New York: Nasdaq schwach nach starkem Jahr - Medline-Börsengang im Blick | NEW YORK (dpa-AFX) - Die US-Börsen haben am Mittwoch erneut nachgegeben. Die Wall Street und vor allem die technologielastige Nasdaq zollten ihrem starken Lauf im Jahr 2025 weiter Tribut. Sorgen über... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 35,590 | 0,00 % | BrightSpring upgraded at KeyBanc on specialty pharmacy and EBITDA prospects | ||
| HEARTBEAM | 3,060 | 0,00 % | Heartbeam stock is a buy, this analyst says | ||
| PROGYNY | 26,010 | 0,00 % | Progyny, Inc. - 8-K, Current Report | ||
| SIEMENS HEALTHINEERS | 44,390 | -0,56 % | Moody's vergibt Investmentgrade-Rating "A3" an Siemens Healthineers | DJ Moody's vergibt Investmentgrade-Rating "A3" an Siemens Healthineers
DOW JONES--Moody's hat Siemens Healthineers die Bonitätsbewertung A3 gegeben, was als sichere Anlage gilt. Der Ausblick ist... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,160 | -0,35 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,550 | 0,00 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| FRESENIUS | 47,890 | +0,23 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Fresenius mit einem Kursziel von 53,60 Euro auf "Overweight" belassen. Die Veranstaltung mit dem Biopharma-Management der Bad... ► Artikel lesen | |
| BETA BIONICS | 29,200 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| GENEDX | 135,46 | 0,00 % | GeneDx and Guardant Health named as BTIG's top picks for 2026 | ||
| PROCEPT BIOROBOTICS | 33,780 | 0,00 % | UBS stuft Procept BioRobotics mit "Buy" ein - Wachstum bei Systemauslastung als Treiber | ||
| RXSIGHT | 12,620 | 0,00 % | Pre-market Movers: Basel Medical Group, SOBR Safe, ProKidney, RxSight, Mustang Bio | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green Basel Medical Group Ltd (BMGL) is up over 88% at... ► Artikel lesen | |
| NUTEX HEALTH | 159,17 | 0,00 % | Nutex Health, Inc.: Nutex Health Responds To Short Seller Report | HOUSTON, Nov. 26, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), is aware of a short seller report issued on November... ► Artikel lesen | |
| CLEARPOINT NEURO | 13,550 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Completes Acquisition of IRRAS | Acquisition Will Enhance ClearPoint Neuro's Commercial Scale, Drive Operational Leverage, and Support Its Long-Term Strategy in CNS Drug Delivery Innovation SOLANA BEACH, CALIFORNIA / ACCESS Newswire... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,915 | +0,51 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen |
Das Unternehmen SANUWAVE HEALTH INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 32,110 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SANUWAVE HEALTH INC finden Sie auf Wallstreet Online.